COMP <GO>
SSII vs MRK // ENTERPRISE SCALE & MARKET CAP
SS Innovations International Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: SSII 2
— MRK 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $2.35 (-1.26%) • MKT CAP: $477.2M
market-cap
$477.2M
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SSII VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SSII | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.00% | 74.80% | -28.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.50% | 20.70% | -39.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.65% | 3.42% | -8.07 | MRK | /fcf-yield <GO> |
| Operating Margin | -19.30% | 34.30% | -53.60 | MRK | /operating-margins <GO> |
| Net Profit Margin | -28.50% | 28.10% | -56.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 105.70% | 1.30% | +104.40 | SSII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.47 | 5.19 | +2.28 | SSII | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.7 | 51.7 | -14.00 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $477.2M | $361.02B | -$360.54B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SSII REV | MRK REV | SSII GROSS % | MRK GROSS % | SSII FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $42.5M | $65.01B | 46.0% | 74.8% | -$22.2M | $12.36B |
| FY 2024 | $20.6M | $64.17B | 40.9% | 76.3% | -$10.2M | $18.10B |
| FY 2023 | $5.9M | $60.12B | — | — | -$15.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SSII // BETA —
MRK // BETA 0.92